AI assistant
ORTHOCELL LIMITED — Director's Dealing 2019
Aug 25, 2019
65477_rns_2019-08-25_cbf0c487-d6bc-4cf5-93a1-77c3dd630216.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Z Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Orthocell Limited ACN 57 118 897 135
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | Matthew Callahan |
|---|---|
| Date of last notice | 26/08/2019 |
| Date that director ceased to be director | 23/08/2019 |
Part 1 – Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
Nil
- See chapter 19 for defined terms.
11/3/2002
Appendix 3Z Page 1
Appendix 3Z Final Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest SRV Nominees Pty Ltd Shenasaby Investments Pty Ltd Shenasaby Investments Pty Ltd as trustee for the Shenasaby Trust |
649,177 Ordinary Shares 12,500 Ordinary Shares 419,763 Ordinary Shares 1,850,000 Unlisted Options exercisable at $0.395 expiring 8 May 2021 (vesting conditions set out in NOM for General Meeting held on 7 May 2018) |
|---|---|
Part 3 – Director’s interests in contracts
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| No. and class of securities to which interest relates |
N/A |
- See chapter 19 for defined terms.
Appendix 3Z Page 2
11/3/2002